Enfusion (ENFN)
(Delayed Data from NYSE)
$8.81 USD
+0.11 (1.26%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $8.80 -0.01 (-0.11%) 7:36 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ENFN 8.81 +0.11(1.26%)
Will ENFN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ENFN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENFN
Implied Volatility Surging for Enfusion (ENFN) Stock Options
Enfusion (ENFN) Reports Q1 Earnings: What Key Metrics Have to Say
ENFN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Radware (RDWR) Surpasses Q1 Earnings and Revenue Estimates
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
Other News for ENFN
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating
FTV Capital Expands Internationally with Opening of London Office
Analysts Offer Insights on Technology Companies: NEXTracker, Inc. Class A (NXT), ON Semiconductor (ON) and Enfusion (ENFN)
Analysts Offer Insights on Technology Companies: Enfusion (ENFN) and WalkMe (WKME)